Internal medicine journal
-
Internal medicine journal · Dec 2022
Diagnostic challenges for dementia in Australia: are blood-based biomarkers the solution?
The burden of dementia will increase as the Australian population ages and grows in coming decades. Early and accurate diagnosis remains challenging, and disproportionately so for particular groups, including rural communities. Recent advances in technology, however, now allow reliable measurement of blood biomarkers that could improve diagnosis in a range of settings. We discuss the most promising biomarker candidates for translation into clinical practice and research in the near future.
-
Internal medicine journal · Nov 2022
The short-term outcomes of patients with chronic liver disease hospitalized with COVID-19.
Patients with chronic liver disease (CLD) might have an aggravated course after acquisition of coronavirus disease 2019 (COVID-19). ⋯ Cirrhosis is independently associated with higher 30-day mortality of hospitalised patients with COVID-19.